One Health, or the concept that animal, human, and environmental health are interconnected, has been made readily apparent by the recent COVID-19 pandemic. The World Health Organization estimates that more than 60% of human diseases are zoonotic and that 75% of diseases discovered over the past decade originate in animals. Efforts such as the US Agency for International Development (USAID) PREDICT program have worked over the past decade to increase our knowledge of potential viral threats by identifying viruses that may cause global public health emergencies. How does this increased knowledge translate into biotechnology solutions to ensure we are prepared for zoonotic threats to human health? Hear from public health experts and company leaders about how the biotechnology industry can play a powerful role in finding innovative solutions to macro-level, cross-sectional One Health problems.